A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ER / estrogen

[Related PubMed/MEDLINE]
Total Number of Papers: 809
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ER  (>> Co-occurring Abbreviation)
Long Form:   estrogen
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. DCIS, PgR
2019 Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study. AF, AhR, AR, ASD, EDCs, FDR, OR, PFAS, PFOS
2019 Clinicopathological characteristics of metaplastic breast cancer-analysis of the basic immunohistochemical profile andcomparison with other invasive breast cancer types. MpBC, PR
2019 Dietary Glycemic Index and Glycemic Load and Risk of Breast Cancer by Molecular Subtype in Mexican Women. BC, GI, GL, HER2, PR, TN
2019 Evaluation of the value of GATA3 combined with E-cadherin in the diagnosis of breast cancer. ELISA, HER2, PR
2019 Expression of androgen, estrogen, and progesterone hormone receptors in the penile tissues of children with different types of hypospadias. AR, PR
2019 HER-2/Neu and Hormone Receptor Analysis in Breast Carcinomas and Their Association with Clinicopathologic Parameters. FISH, IC-NST, IHC, PR
2019 Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands. IBC, PR
2019 Hypofractionated radiation in older women with breast cancer. IMRT, PR
10  2019 Imaging Cobalamin Uptake within Malignant Breast Tumors In Vivo. Cbl, DEX, HER2, P.I, PC, PR, SPECT, TN, WBP
11  2019 Liraglutide treatment effects on rat ovarian and uterine tissues. CAT, FSH, GLP-1, LH, MDA, PR, SOD
12  2019 Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies. CI, HR, NHS, PR
13  2019 Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903. PD, PFS, PR, QOL
14  2019 Prognostic markers in salivary gland cancer and their impact on survival. AR, DFS, EGFR, HER2, OS, PD-L1, PR, SGC, TIMC
15  2019 Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material. NAT, PR
16  2019 Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas. PR
17  2019 Role of Melatonin in Breast Carcinoma: Correlation of Expression Patterns of Melatonin-1 Receptor With Estrogen, Progesterone, and HER2 Receptors. MT1, PR
18  2019 Suboptimal concordance in testing and retesting results of triple-negative breast carcinoma cases among laboratories: one institution experience. PR, TNBC
19  2019 The role of histopathologic testing on apocrine carcinoma of the breast. GCDFP-15, PR
20  2019 Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015-2018. IHC, LI, PR
21  2019 Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo. 3'-UTRs, HER2, miRNAs, PR
22  2019 [10]-Gingerol Affects Multiple Metastatic Processes and Induces Apoptosis in MDAMB- 231 Breast Tumor Cells. HER2, PR, TNBC
23  2018 Assessment of endocrine disruption and oxidative potential of bisphenol-A, triclosan, nonylphenol, diethylhexyl phthalate, galaxolide, and carbamazepine, common contaminants of municipal biosolids. AhR, AR, BPA, DEHP, TCS, tNP, TTR
24  2018 Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells. HER2, PR, TNBC
25  2018 Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review. CI, MBC
26  2018 Correlation of Serum Levels of Urokinase Activation Plasminogen (uPA) and Its Inhibitor (PAI-1) with Hormonal and HER-2 Status in the Early Invasive Breast Cancer. PgR, uPA
27  2018 ER-/PR+ subset of invasive breast carcinoma (IBC): a distinct phenotype with good prognosis. DFS, IBC, OS, PR
28  2018 Estrogen and progesterone signalling in the normal breast and its implications for cancer development. PR
29  2018 Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. AR, PR, SDC, SGTs
30  2018 Expression of hormone receptors in oropharyngeal squamous cell carcinoma. AR, HPV, OPSCC, PR
31  2018 High level of C-type natriuretic peptide induced by hyperandrogen-mediated anovulation in polycystic ovary syndrome mice. AR, DHEA, hCG, LH, PCOS
32  2018 Identification of mitochondrial hormone receptors in avian muscle cells. GR, PR, TR
33  2018 Immunophenotypic profile of tumor buds in breast cancer. BC, HR, ngTMA, PgR
34  2018 In Vitro Tissue Microarrays for Quick and Efficient Spheroid Characterization. PR
35  2018 Incorporation of metabolic enzymes to improve predictivity of reporter gene assay results for estrogenic and anti-androgenic activity. AR
36  2018 Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups. BC, HER2, IL-7, IL-7Ralpha, PR
37  2018 Organized screening detects breast cancer at earlier stage regardless of molecular phenotype. PR
38  2018 Overview on Epigenetic Re-programming: A Potential Therapeutic Intervention in Triple Negative Breast Cancers PR, PRC, TNBCs
39  2018 Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67. CI, DFS, HR, OR, PR, TMB
41  2018 Src Kinase Dependent Rapid Non-genomic Modulation of Hippocampal Spinogenesis Induced by Androgen and Estrogen. AR, DHT
42  2018 SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner. PR
43  2018 Ten-Year Survival after Liver Resection for Breast Metastases: A Single-Center Experience. PR
44  2018 Tissue Expression of Prohibition-I and It's Relationship With Prognostic Factors in Breast Cancer. IHC, PHB, PR
45  2017 Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania. MNH, MRM, PgR, SPSS, TNBC
46  2017 Clinicopathological features of patients with breast cancer aged 70 years or over. BC, DFS, HER2, LNI, LVI, OS, PgR, PNI
47  2017 Collagen concentration on the facial skin of postmenopausal women after topical treatment with estradiol and genistein: a randomized double-blind controlled trial. GEN, UNIFESP
48  2017 Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes. CBBCT, HER2, PR
49  2017 Effect of Hydrochloric Acid Decalcification on Expression Pattern of Prognostic Markers in Invasive Breast Carcinomas. BC, HCl, IHC, PR
50  2017 Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors. IDC, ILC, PR
51  2017 Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer. CNB, DCIS, HER2, IBC, OR, PR
52  2017 Evaluation of Immunohistochemistry-Equivocal (2+) HER2 Gene Status in Invasive Breast Cancer by Silver DNA in Situ Hybridization (SISH) and its Association with Clinicopathological Variables. PR, SISH
53  2017 Gene Expression Assays for Early-Stage Hormone Receptor-Positive Breast Cancer: Understanding the Differences. ASCO, BCI, PAM50, PR
54  2017 Genome-wide miRNA, gene and methylation analysis of triple negative breast cancer to identify changes associated with lymph node metastases. PR, TNBC
55  2017 Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : Amonocentric clinicopathologic analysis. AR, DFS, DMFS, EGFR, LRC, PD-L1-R, PR, SDC
56  2017 Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)? DCIS, IDC, MRI, PR
57  2017 Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis. CBR, EC, HR, HT, ORR, OS, PFS, PgR
58  2017 Occurrence and In Vitro Bioactivity of Estrogen, Androgen, and Glucocorticoid Compounds in a Nationwide Screen of United States Stream Waters. AR, GR
59  2017 Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation. APBI, BCST, CSS, DFS, DM, IBTR, LA, LB, OS, PR
60  2017 Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells In Vitro. PR, VDR
61  2017 Prognostic role of progesterone receptor expression in a population-based analysis. HER2, PR
62  2017 Prognostic value of primary tumor SUVmax on F-18 FDG PET/CT compared with semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer. ANS, BSGI, IDC, PR, PTS, TNRs
63  2017 Steroid and Xenobiotic Receptor Signalling in Apoptosis and Autophagy of the Nervous System. AhR, AR, GR, MR, PPARs, PR
64  2017 Steroid hormone receptors and direct effects of steroid hormones on ram spermatozoa. PR
65  2017 Synergistic Action of Genistein and Calcitriol in Immature Osteosarcoma MG-63 Cells by SGPL1 Up-Regulation. S1P, SGPL1, VDR
66  2017 The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival. AR, ECs, PR
67  2017 The positivity of estrogen receptor and progesterone receptor may not be associated with metastasis and recurrence in epithelial ovarian cancer. PR
68  2017 The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges. PR, TNBC
69  2017 Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients. 7NP, BLBCs, CK, DCIS, EGFR, HER2, IHC, PR, TNBCs
70  2016 An overview of the effective combination therapies for the treatment of breast cancer. BC, PR, TNBC
71  2016 Androgen receptor as potential therapeutic target in metastatic endometrial cancer. AR, PR
72  2016 Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models. BWE, MMP-3, MPA, PR
73  2016 beta-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. ---
74  2016 Case report of metastatic invasive breast lobular carcinoma to the urinary bladder. PR
75  2016 CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer. BC, HER2, PR
76  2016 Circulating Tumor Cells in Breast Cancer: Correlation with Clinicopathological Parameters, Hormone Profile and MicroRNA Polymorphisms. PR
77  2016 Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients. BC, CTCs, PR
78  2016 Concurrent Androgen and Estrogen Ablation and Inhibition of Steroid Biosynthetic Enzyme Treatment for Castration-resistant Prostate Cancer. AR, CRPC, DES, PCa
79  2016 Effects of low dose of tibolone on steroid receptors and Bcl-2 on the postmenopausal endometrium. HRT, PR
80  2016 Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review. PR
81  2016 Estrogenicity and androgenicity screening of PCB sulfate monoesters in human breast cancer MCF-7 cells. AR, HO-PCBs, PCB
82  2016 Expression of sodium iodide symporter in human breast tissues. BBD, BC, PR
83  2016 Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET. GRPR, PET, PR
84  2016 Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex. AR, PgR
85  2016 Hypothyroidism advances mammary involution in lactating rats through inhibition of PRL signaling and induction of LIF/STAT3 mRNAs. HypoT, PR, PTU, TR
86  2016 Intraocular Metastases Secondary to Breast Carcinoma Correlates With Upregulation of Estrogen and Progesterone Receptor Expression in the Primary Tumor. BC, HER2, PR
87  2016 Lymphovascular infiltration in the tumor bed is a useful marker of biological behavior in breast cancer. DFS, PLI, PR, PVI
88  2016 Male breast cancer: Looking for better prognostic subgroups. AR, FBC, MBC, PR
89  2016 Mechanism of action of the breast cancer-promoter hormone, 5alpha-dihydroprogesterone (5alphaP), involves plasma membrane-associated receptors and MAPK activation. 5alphaP, 5aP, MAPK, PR
90  2016 Metaplastic Breast Carcinoma: Analysis of Clinical and Pathologic Characteristics - A Case Series. MBC, PR, SCC
91  2016 Methoxychlor and Vinclozolin Induce Rapid Changes in Intercellular and Intracellular Signaling in Liver Progenitor Cells. AR, GJIC, MAPKs, MXC, PC-PLC, VIN
92  2016 Obesity and Breast Cancer. HRT, PR
93  2016 Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study. CHREC, CHREC, ESC, PR
94  2016 Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry. BMBC, BMBC, BMs, BMs, CT, HER2, MRI, PR
95  2016 Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population. CI, GWAS, HER2, OR, PR
96  2016 Sleep duration and breast cancer risk among black and white women. PR, SCCS
97  2016 Stromal Clues in Endometrial Carcinoma: Loss of Expression of beta-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor. EC, PR
98  2016 Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model. AR, ARO, PDE5i, TAD
99  2016 The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors. CSCs, PR
100  2016 The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study. AUC, MBC, OS, PR